CAMT:TASECamtek Ltd Analysis
Data as of 2026-03-12 - not real-time
$161.35
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Camtek Ltd. (CAMT) is trading at $161.35, comfortably above its 20‑day SMA of 159.93 and the 50‑day SMA of 146.33, indicating short‑term bullish momentum despite a recent earnings miss where EPS came in at $0.81 versus the $0.83 consensus. The RSI sits near the mid‑range at 54.5, suggesting neither overbought nor oversold conditions, while the MACD histogram is negative (-1.63) and the signal line is bearish, hinting at potential downside pressure. Fundamental metrics reveal a steep trailing P/E of 152x versus an industry average of 34.6x, marking the stock as significantly overvalued, though the forward P/E of 37x offers a slightly more tempered view. Revenue for FY‑2025 reached $496 million, up 9% YoY, and forward EPS is projected to rise to $4.33, underscoring solid growth prospects. The balance sheet is cash‑rich with $668 million in cash against $520 million of debt, yielding a debt‑to‑equity of 84%, and the company generates no dividend.
The stock’s beta of 1.84 and 30‑day volatility of over 66% signal heightened market sensitivity, while volume trends are decreasing, adding a liquidity caution. Analyst consensus remains positive with a “buy” rating from 12 analysts and a median price target of $175, reflecting confidence in the company’s advanced packaging platform and AI‑driven inspection tools. However, the combination of high valuation multiples, earnings miss, and elevated risk metrics suggests a measured approach: hold in the near term, consider buying on pull‑backs, and monitor macro‑ and geopolitical factors that could affect its global customer base.
The stock’s beta of 1.84 and 30‑day volatility of over 66% signal heightened market sensitivity, while volume trends are decreasing, adding a liquidity caution. Analyst consensus remains positive with a “buy” rating from 12 analysts and a median price target of $175, reflecting confidence in the company’s advanced packaging platform and AI‑driven inspection tools. However, the combination of high valuation multiples, earnings miss, and elevated risk metrics suggests a measured approach: hold in the near term, consider buying on pull‑backs, and monitor macro‑ and geopolitical factors that could affect its global customer base.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term SMAs but MACD bearish divergence
- Recent EPS miss versus consensus
- Elevated valuation multiples
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Solid revenue growth and strong forward EPS outlook
- Robust cash position relative to debt
- Analyst consensus and price‑target upside
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Long‑term secular demand for advanced packaging inspection
- Persistent overvaluation relative to peers
- High beta and volatility warrant cautious exposure
Key Metrics & Analysis
Financial Health
Revenue Growth9.20%
Profit Margin10.22%
P/E Ratio152.2
ROE8.70%
ROA7.48%
Debt/Equity84.25
P/B Ratio12.0
Industry P/E34.6
Technical Analysis
TrendBullish
RSI54.5
Support$142.35
Resistance$174.61
MA 20$159.93
MA 50$146.33
MA 200$108.80
MACDBearish
VolumeDecreasing
Fear & Greed Index78.16
Valuation
Target Price$168.83
Upside/Downside4.64%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.84
Volatility66.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.